Skip to main content
. 2024 May 6;12(13):2173–2181. doi: 10.12998/wjcc.v12.i13.2173

Table 2.

Comparison of total bilirubin, alanine transaminase, aspartate aminotransferase, creatinine, and glomerular filtration rate in both groups

Group
TBIL (μmol/L)
ALT (U/L)
AST (U/L)
Cr (μmol/L)
GFR (mL/min)
Control group (n = 26)
    Before treatment 43.4 ± 20.97a 42.35 ± 4.55a 40.29 ± 9.16 78.54 ± 15.67 97.28 ± 23.06
    After treatment 23.43 ± 5.28 35.96 ± 3.66 39.88 ± 8.54 85.46 ± 12.67 102.87 ± 30.24
Treatment group (n = 28)
    Before treatment 38.92 ± 5.04 46.75 ± 7.43 43.11 ± 7.28 77.89 ± 15.38 92.45 ± 20.33
    After treatment 38.26 ± 9.16 41.13 ± 8.75 42.54 ± 10.01 72.34 ± 16,43 98.29 ± 18.98
a

P < 0.05, compared with before treatment.

TBIL: Total bilirubin; ALT: Alanine transaminase; AST: Aspartate aminotransferase; Cr: Creatinine; GFR: Glomerular filtration rate.